Roper Industries (NYSE: ROP) reported Q1 EPS of $1.50, $0.04 better than the analyst estimate of $1.46. Revenue for the quarter came in at $902 million versus the consensus estimate of $895.87 million.

"We are very pleased with our performance in the quarter," said Brian Jellison, Roper's Chairman, President and CEO. "Although energy markets were weak as expected, strong contributions from our software and medical products businesses resulted in record revenue for the quarter. Our businesses continued to generate strong margin performance, with gross margin expansion in all four segments. In addition, orders strengthened across the enterprise, with three segments recording a book-to-bill ratio of 1.03 or greater."

"During the quarter we completed the acquisition of Clinisys Group, Ltd., adding to our platform of software solutions for hospital laboratories," Mr. Jellison continued. "In addition, we acquired PCI Medical, a provider of disinfection systems that complement our Civco Medical Solutions business. Roper's pipeline of acquisition opportunities remains attractive and the Company expects to deploy over $1 billion in 2016."

GUIDANCE:

Roper Industries sees Q2 2016 EPS of $1.56-$1.61, versus the consensus of $1.74.

Roper Industries sees FY2016 EPS of $6.85-$7.15, versus the consensus of $7.02.

For earnings history and earnings-related data on Roper Industries (ROP) click here.